Statins and Risk of Thrombosis in Critically ill Patients with COVID-19: A Multicenter Cohort Study

PURPOSE: Coagulation abnormalities are one of the most important complications of severe COVID-19, which might lead to venous thromboembolism (VTE). Hypercoagulability with hyperfibrinogenemia causes large vessel thrombosis and major thromboembolic sequelae. Statins are potentially a potent adjuvant...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Harbi, Shmeylan, Kensara, Raed, Aljuhani, Ohoud, Korayem, Ghazwa B., Altebainawi, Ali F., Al Harthi, Abdullah, Vishwakarma, Ramesh, Alenazi, Alaa M., Almutairi, Abdulmajed, Alshaya, Omar, Alraddadi, Sultan, Al Sulaiman, Tareq, Aldakkan, Latifah, Mahboob, Reem, Alaamer, Kholoud, Alissa, Abdulrahman, Hafiz, Awatif, Aldhayyan, Nada, Althewaibi, Sara, Alenezi, Farhan, Alkhotani, Nadeen Y., Alghamdi, Sara A., Alenazi, Abeer A., Al Sulaiman, Khalid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Manuscript
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178978/
https://www.ncbi.nlm.nih.gov/pubmed/35658686
http://dx.doi.org/10.1177/10760296221103864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178978/
https://www.ncbi.nlm.nih.gov/pubmed/35658686
http://dx.doi.org/10.1177/10760296221103864

Ejemplares similares